Magazine April 20, 2020, Issue

Pharmaceuticals and the Coronavirus Pandemic

(Lerexis/Getty Images)
A primer

‘When can we end social distancing and get back to normal life?” It’s the question on everyone’s mind, and one without a clear answer at this time. Here’s what we do know: An effective treatment against the novel coronavirus would make a big difference in getting us there.

Remember the old adage, “There’s no cure for the common cold”? Well, the common cold is caused by a mild strain of coronavirus. The version of coronavirus we’re dealing with here is far more dangerous — but possibly just as difficult to treat.

In order to talk about therapies, it’s important to distinguish between

This article appears as “What Drugs Can Do” in the April 20, 2020, print edition of National Review.

Something to Consider

If you enjoyed this article, we have a proposition for you: Join NRPLUS. Members get all of our content (including the magazine), no paywalls or content meters, an advertising-minimal experience, and unique access to our writers and editors (through conference calls, social media groups, and more). And importantly, NRPLUS members help keep NR going.

If you enjoyed this article and want to see more content like this, we have a proposition for you: Join NRPLUS.


Join Now
Avik RoyMr. Roy, the president of the Foundation for Research on Equal Opportunity, is a former policy adviser to Mitt Romney, Rick Perry, and Marco Rubio.

In This Issue

Coronavirus Issue

Books, Arts & Manners


The Week

The Week

Trump has every right to boast about his TV ratings, but he really ought to give the virus some of the credit.


The Latest